Anmeldung erfolgt in Kürze...
Details werden geladen...
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program | FDA
The U.S. Food and Drug Administration today approved Otarmeni (lunsotogene parvec-cwha), the first-ever dual adeno-associated virus (AAV) vector-based gene therapy.
Ähnliche Seiten
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss Under National Priority Voucher Program | The Manila Times
https://www.manilatimes.net/2026/04/24/tmt-newswire/globenewswire/fda-approves-first-ever-gene-therapy-for-treatment-of-genetic-hearing-loss-under-national-priority-voucher-program/2327730
FDA Approves First-Ever Gene Therapy for Treatment of Genetic Hearing Loss | Hacker News
https://news.ycombinator.com/item?id=47919733
FDA approves Otarmeni as first-ever gene therapy for genetic hearing loss | Fox News
https://www.foxnews.com/health/first-ever-gene-therapy-hearing-loss-gets-fda-approval-groundbreaking
FDA approval of Regeneron’s hearing loss gene therapy breaks barriers - BioSpace
https://www.biospace.com/fda/fda-approval-of-regenerons-hearing-loss-gene-therapy-breaks-barriers
Updated: Regeneron snags hearing loss gene therapy approval, closes US pricing deal
https://endpoints.news/fda-approves-regeneron-hearing-loss-gene-therapy-otarmeni/